The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium

OBJECTIVE: To determine whether the heterogeneous clinical response to tumour necrosis factor (TNF)α blocking therapy in rheumatoid arthritis (RA) can be predicted by TNFα expression in the synovium before initiation of treatment. METHODS: Prior to initiation of infliximab treatment, arthroscopic sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijbrandts, C A, Dijkgraaf, M G W, Kraan, M C, Vinkenoog, M, Smeets, T J, Dinant, H, Vos, K, Lems, W F, Wolbink, G J, Sijpkens, D, Dijkmans, B A C, Tak, P P
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Extended Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564801/
https://www.ncbi.nlm.nih.gov/pubmed/18055470
http://dx.doi.org/10.1136/ard.2007.080440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2564801/
https://www.ncbi.nlm.nih.gov/pubmed/18055470
http://dx.doi.org/10.1136/ard.2007.080440

Ejemplares similares